Хлебные крошки
- Главная
-
Аналитика
-
Акции
Акции внутренные
Quanterix Corporation QTRX
$16.10
-$0.68 (-4.22%)
На 18:00, 12 мая 2023
-19.25%
Потенциал через год
Ранг: 3
Ключевые показатели
-
Marketcap
625218968.00000000
-
week52high
20.20
-
week52low
6.31
-
Revenue
104952000
-
P/E TTM
-7
-
Beta
1.33356400
-
EPS
-3.39000000
-
Last Dividend
0.00000000
-
Next Earnings Date
09 мая 2023 г. в 20:00
Описание компании
Quanterix Corporation, a life sciences company, engages in development and marketing of digital immunoassay platforms that advances precision health for life sciences research and diagnostics in North America, Europe, the Middle East, Africa, and the Asia Pacific regions. It offers HD-X instrument, a sensitive automated multiplex protein detection platform; and SR-X instrument that enables researchers to apply Simoa detection technology in various applications, including direct detection of nucleic acids. The company also provides SP-X instrument that is based on Simoa planar array technology for the measurement of multiplex chemiluminescent immunoassays. The company's products include assay kits and other consumables such as reagents. In addition, it offers contract research services, including sample testing, homebrew assay development, and custom development services. The company primarily operates in the areas of neurology, oncology, cardiology, infectious diseases, and inflammation. It sells its products for the life science research sector primarily to laboratories associated with academic and governmental research institutions, as well as pharmaceutical, biotechnology, and contract research companies through a direct sales force, support organizations, and distributors or sales agents. The company was formerly known as Digital Genomics, Inc. and changed its name to Quanterix Corporation in August 2007. Quanterix Corporation was incorporated in 2007 and is headquartered in Billerica, Massachusetts.
Рекомендации
аналитиков
Рекомендации аналитиков
| Grading company | New grade | Previous grade | Recommendation date |
|---|---|---|---|
| Canaccord Genuity | Hold | Buy | 15 авг 2022 г. |
| Goldman Sachs | Neutral | Neutral | 10 авг 2022 г. |
| SVB Leerink | Market Perform | Outperform | 09 авг 2022 г. |
| Cowen & Co. | Market Perform | Outperform | 09 авг 2022 г. |
| Goldman Sachs | Neutral | Neutral | 14 июл 2022 г. |
| Goldman Sachs | Neutral | Neutral | 10 ноя 2022 г. |
| SVB Leerink | Market Perform | Market Perform | 09 ноя 2022 г. |
Свежие комментарии
Свежие комментарии
Оставьте свой голос
Оставьте свой голос
Анонимное голосование
Будет ли рост российского рынка к концу года?
-
Да
87% -
Нет
12%
Проголосовал 8 человек
Новостная лента
компании
Insider Summary
Insider Summary
| Reporting Name | Acquistion/Disposition | Owned | Transacted | Transaction Date |
|---|---|---|---|---|
| DOYLE MICHAEL A | D | 48426 | 41 | 31 янв 2023 г. |
| Toloue Masoud | D | 185330 | 493 | 31 янв 2023 г. |
| Blaser Brian J | A | 24153 | 24153 | 06 янв 2023 г. |
| Blaser Brian J | A | 16102 | 16102 | 06 янв 2023 г. |
| MEISTER PAUL M | A | 12124 | 12124 | 03 янв 2023 г. |
| MEISTER PAUL M | A | 263291 | 1166 | 03 янв 2023 г. |
| MEISTER PAUL M | A | 262125 | 8083 | 03 янв 2023 г. |
| OLSON LAURIE J | A | 12124 | 12124 | 03 янв 2023 г. |
| OLSON LAURIE J | A | 15291 | 8083 | 03 янв 2023 г. |
| Madaus Martin D | A | 12124 | 12124 | 03 янв 2023 г. |
Новостная лента
Quanterix Corporation (QTRX) Reports Q1 Loss, Tops Revenue Estimates
Zacks Investment Research
09 мая 2023 г. в 18:20
Quanterix Corporation (QTRX) came out with a quarterly loss of $0.16 per share versus the Zacks Consensus Estimate of a loss of $0.36. This compares to loss of $0.49 per share a year ago.
Quanterix Corporation (QTRX) Soars 33.7%: Is Further Upside Left in the Stock?
Zacks Investment Research
04 мая 2023 г. в 13:41
Quanterix Corporation (QTRX) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
Quanterix's First Quarter 2023 Earnings Conference Call
Business Wire
02 мая 2023 г. в 16:30
BILLERICA, Mass.--(BUSINESS WIRE)--Quanterix Corporation (NASDAQ: QTRX), a company fueling scientific discovery through ultrasensitive biomarker detection, today announced it will host a conference call on Tuesday, May 9, 2023, to discuss its first quarter 2023 financial results. The call will begin at 4:30 PM Eastern Time. It will be hosted by Masoud Toloue, the Company's President and Chief Executive Officer, and Michael Doyle, the Company's Chief Financial Officer. Quanterix will issue a pre.
Quanterix Corporation (QTRX) Reports Q4 Loss, Misses Revenue Estimates
Zacks Investment Research
06 мар 2023 г. в 11:17
Quanterix Corporation (QTRX) delivered earnings and revenue surprises of 5.66% and 1.28%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
Quanterix to Present at Cowen's 43rd Annual Health Care Conference
Business Wire
28 февр 2023 г. в 16:30
BILLERICA, Mass.--(BUSINESS WIRE)--Quanterix Corporation (NASDAQ: QTRX), a company fueling scientific discovery through ultrasensitive biomarker detection, today announced that Chief Executive Officer Masoud Toloue will present at Cowen's 43rd Annual Health Care Conference. Quanterix's session will take place on Tuesday, March 7, 2023, at 9:50 a.m. EST and will be made available to attendees and, via webcast, the general public.